So our highlights are we have a marketed product generic Enoxaparin was approved by the FDA in July of 2010 it was the most successful generic launch in history and it’s first running quarters have generated more than $1 billion in net sales by our …
-
-
Recent Posts
- Momenta Pharmaceuticals’ Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript) – Seekingalpha.com
- Celebrities make pitch for patient safety panel – AMA
- Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule – Elites TV
- SickKids: Elisa Linton’s Sanfilippo Syndrome prompted her parents to create a research foundation in her name – Toronto Star
- Benefit run, walk planned for Fort Scott youngster with rare disease – Fort Scott Tribune
Categories